Challenges and drivers for development of Long Acting Injectables
SMi Reports: Renowned industry experts from MedinCell and Janssen to present on the Pre-Filled Syringes and Injectable Drug Devices pre-conference workshop taking place 12th January 2021.
- (1888PressRelease) October 08, 2020 - The Workshop will give an overview of the landscape of long acting injectable technologies, addressing the key barriers facing development in industry and discussing strategies in overcoming hurdles in sustained-release delivery. Delegates will engage in an interactive case study review to explore the best approaches and strategies for long acting injectable development and optimal delivery. Further discussion will delve into the future potential for long-acting injectables.
View the full agenda and speaker line-up online: www.pre-filled-syringes.com/1888pr3
Benefits of attending:
Assess the current landscape for fragile molecule formulations and delivery
Explore real world examples through injectable device case studies
Discuss considerations and strategies for successful long-acting injectable delivery
Gain insight into the future landscape of long acting injectables
Workshop Leaders discussing:
Dr Jo๋l Richard, Chief Development Officer, MedinCell
Ren้ Holm, Head & Scientific Director, Janssen
AN OVERVIEW OF TECHNOLOGIES FOR LONG ACTING INJECTABLES
Current successful technologies in industry
What are the limitations and barriers facing development?
Competitive advantages of injectable in situ forming implant technologies
How do we select compounds for long acting injectables?
FORMULATIONS OF FRAGILE MOLECULES
Current landscape for delivery of fragile molecules
Specific formulation challenges for peptides and proteins
Overcoming hurdles in fragile molecule sustained-release delivery
CASE STUDY INTRODUCTION
Delegates will be presented with a case study overview of the BEPOฎ long acting injectable
Recent progress of BEPOฎ
Challenges in development of the long acting injectables and considerations in formulation development
INTERACTIVE CASE STUDY REVIEW
Delegates will be tasked to assess and discuss:
Best approaches for development
Strategies to overcome formulation challenges
Brainstorm improvements for optimal delivery
Discussion of lessons learned from the exercise
Future potential for long acting injectables
Register online: www.pre-filled-syringes.com/1888pr3
Who should attend:
Drug-delivery developers
Medical Device Engineers
Primary Packaging material designers
Secondary packagers
Smart device developers
Training device developers
Device-safety solution providers
Drug developers
Pre-Filled Syringes and Injectable Drug Devices Conference
13th 14th January 2021
London, UK
Sponsored by BD Medical| Harro Hoefliger | Nemera | Owen Mumford | Zeon |
Contact Information:
For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu ( @ ) smi-online dot co dot uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam